Data as of Dec 19
| +0.355 / +2.71%|
The 6 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 22.00, with a high estimate of 31.00 and a low estimate of 13.00. The median estimate represents a +63.69% increase from the last price of 13.44.
The current consensus among 6 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.